4//SEC Filing
Bancroft Robert E. 4
Accession 0001610717-25-000120
CIK 0001837607other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:17 PM ET
Size
4.7 KB
Accession
0001610717-25-000120
Insider Transaction Report
Form 4
Bancroft Robert E.
DirectorPresident & CEO
Transactions
- Award
Class A Common Stock
2025-05-14+177,103→ 177,103 total
Footnotes (1)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Class A Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on each anniversary of April 29, 2025.
Documents
Issuer
AEON Biopharma, Inc.
CIK 0001837607
Entity typeother
Related Parties
1- filerCIK 0002066370
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:17 PM ET
- Size
- 4.7 KB